failed trials

Tonix Ends Depression Drug Trial After Phase 2 Flop

Tonix Pharmaceuticals Abandons Depression Drug Post-Phase 2 Failure

Anika Sharma

Tonix Pharmaceuticals has experienced a setback in its pipeline as it discontinues the development of a major depression disorder (MDD) ...

Evelo’s microbiome platform flops in trial

Evelo seeks new partner after microbiome platform fails to beat placebo

Anika Sharma

In a series of unfortunate turns, Evelo Biosciences, a biotech company backed by Flagship Ventures and that went public in ...

Sotio’s IL-15 drug fails in solid tumors

Sotio halts trials of IL-15 drug in solid tumors due to lack of efficacy, casting doubt on cytokine’s potential

Anika Sharma

Sotio Biotech has decided to halt ongoing studies of its IL-15 superagonist, nanrilkefusp alfa, due to insufficient efficacy in clinical ...

Acelyrin, clinical trial data, inflammatory diseases, failed trials, ulcerative colitis, phase 3 trial, IPO, stock price

Acelyrin’s lead drug flops in phase 3 trial, wiping out half of its market value

Anika Sharma

Acelyrin, a biotech company based in Los Angeles, has delivered a shocking blow to its investors. Despite successfully raising an ...